Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 12.65

(-1.94%)

Revenue Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual revenue in 2023 was 1.03 Million TWD , down -61.46% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly revenue in 2024 Q2 was 2.35 Million TWD , up 100.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a annual revenue of 2.68 Million TWD in annual revenue 2022, down 0.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a annual revenue of - TWD in annual revenue 2021, down 0.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly revenue of 2.35 Million TWD for 2024 Q1, up 356.63% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly revenue of - TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Revenue of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Revenue Revenue Growth
2023 1.03 Million TWD -61.46%
2022 2.68 Million TWD 0.0%
2021 - TWD 0.0%
2020 - TWD 0.0%
2019 - TWD 0.0%

Peer Revenue Comparison of Mercury Biopharmaceutical Corporation

Name Revenue Revenue Difference
Allied Biotech Corporation 720.43 Million TWD 99.857%
GeneFerm Biotechnology Co., Ltd. 793.77 Million TWD 99.87%
Easywell Biomedicals, Inc. 271.62 Million TWD 99.62%
TTY Biopharm Company Limited 5.5 Billion TWD 99.981%
Synmosa Biopharma Corporation 5.14 Billion TWD 99.98%
Orient EuroPharma Co., Ltd. 4.59 Billion TWD 99.978%
Center Laboratories, Inc. 1.39 Billion TWD 99.926%
Tien Liang BioTech Co., Ltd. 459.99 Million TWD 99.775%
Orient Pharma Co., Ltd. 889.91 Million TWD 99.884%
InnoPharmax Inc. 46.07 Million TWD 97.758%
Johnson Chemical Pharmaceutical Works Co., Ltd. 606.71 Million TWD 99.83%
Excelsior Biopharma Inc. 771.56 Million TWD 99.866%
DV Biomed Co., Ltd. 1.53 Billion TWD 99.933%
Foresee Pharmaceuticals Co., Ltd. 195.03 Million TWD 99.47%
Handa Pharmaceuticals, Inc. 1.1 Billion TWD 99.907%
UniPharma Co., Ltd. 103.22 Million TWD 98.999%
Anxo Pharmaceutical Co., Ltd. 939.94 Million TWD 99.89%
Alar Pharmaceuticals Inc. 469.27 Million TWD 99.78%
Winston Medical Supply Co., Ltd. 709.07 Million TWD 99.854%
Bioray Biotech Co., Ltd 191.83 Million TWD 99.462%
TSH Biopharm Corporation Limited 810.91 Million TWD 99.873%